Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Amgen (NQ: AMGN)
236.75 USD  -0.85 (-0.36%)
Official Closing Price  /  Updated: 4:42 PM EST, Jan 22, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 1,998,221
Open 238.75
Bid (Size) 235.11 (1)
Ask (Size) 236.70 (10)
Prev. Close 237.60
Today's Range 235.75 - 239.70
52wk Range 166.30 - 244.99
Shares Outstanding 661,706,000
Dividend Yield 2.23%
Performance
YTD
-1.40%
-1.40%
1 Month
-2.58%
-2.58%
3 Month
+15.58%
+15.58%
6 Month
+34.51%
+34.51%
1 Year
+17.21%
+17.21%
Top News
More News
Free "LabXchange" Science Education Accelerator Launched By Amgen Foundation And Harvard's Faculty Of Arts And Sciences
LabXchange by Amgen Foundation and Harvard's Faculty of Arts and Sciences Reimagines the Science Experience for Students around the Globe Read More
from PR Newswire
Amgen Announces Global Diagnostic Collaborations To Expand Molecular Testing For Patients With Non-Small Cell Lung Cancer
First Company Developing a KRAS(G12C) Inhibitor to Announce Multi-Platform Companion Diagnostics Read More
from PR Newswire
More News
Read More
Amgen To Present At The 38th Annual J.P. Morgan Healthcare Conference
from PR Newswire
9 Takeaways From The JPMorgan Healthcare Conference
category IBB , AMGN , BGNE , and 23 more.
from Benzinga
5 Big Drug/Biotech Stocks Set To Trump Q4 Earnings Estimates
category Stocks / Equities , Pharma/Biotech
from Blogs - TalkMarkets
Noteworthy Thursday Option Activity: MOS, PPG, AMGN
category Stocks
from Market News Video
5 Monster Stocks To Watch For The January 21 Trading Session
category Stocks / Equities
from Blogs - TalkMarkets
3 Attractive Dividend Stocks Whose Dividends Could Double
category BMY , BAC , IIPR , and 2 more.
from Motley Fool
2 Biotechs Battling Immune Diseases
category MNTA , PFE , MYL , and 10 more.
from Motley Fool
Amgen CEO expects 25% of growth to come from Asia in next decade
category companyNews
from Reuters: Company News
Castle Could Crumble When IPO Lockup Expires
category Healthcare , Stocks / Equities
from Blogs - TalkMarkets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.